Impiricus Introduces ‘Ascend’

Impiricus has unveiled Ascend, an AI-driven communication platform intended to simplify how physicians access information and resources from pharmaceutical companies. The company says the system is designed to address longstanding challenges in healthcare communication, where clinicians often face high volumes of digital outreach and inconsistent access to relevant materials.

Ascend uses Impiricus’s data infrastructure, built on more than four billion healthcare-professional data points, to support AI “agents” that facilitate interactions between physicians and life-science organizations. According to Impiricus, sensitive information is processed through tokenized data pipelines intended to protect both personal and patient-related details.

Through the platform, physicians can request product samples, access treatment and dosing information, contact medical science liaisons, or use clinical tools. Impiricus positions Ascend as a way for healthcare professionals to obtain targeted resources without relying on traditional sales-representative outreach.

Company Positioning and Ethical Framing

Impiricus CEO and co-founder Dr. Osama Hashmi describes the effort as part of a broader attempt to create “ethical connections” between the pharmaceutical industry and clinicians. “Ascend gives doctors choice and relevance in how they engage, while giving pharma a responsible way to share information,” Hashmi said.

The platform is also presented as an alternative or supplement to...